Geropharm   Report issue

For profit Phase 1 Phase 3
Founded: St Petersburg Russian Federation (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2016
NCT03604575
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Geropharm